Clinical Trial Update: Magnesium Sulphate in Perinatal Asphyxia [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating magnesium sulfate for perinatal asphyxia in moderate to severe hypoxic-ischemic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy
• Perinatal Asphyxia

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Sheri Kashmir Institute of Medical Sciences | Conditions: Perinatal Asphyxia , Moderate to Severe HIE | Phase 3 | Status: COMPLETED